Differences in protein expression related to inflammatory (IL-1), anti-inflammatory (IL10) and HSP pathways are associated with worse outcome and a model using combinations of quantitative protein expression levels could moderately discriminate worse from less severe outcome, as measured by ICU admission or mortality, among a non-severely ill cohort of patients with sepsis from selected sources. This evidence concerns the gene HSP90B2P and Sepsis.